Amazon, Walgreens, CVS face shortage of heartburn drug being tested as COVID-19 treatment

(By Maia Anderson for Becker’s Hospital Review)

After researchers at New Hyde Park, N.Y.-based Northwell Health announced April 27 that they’re conducting a clinical trial testing a common heartburn drug as a COVID-19 treatment, Amazon, Walgreens and CVS are already facing shortages of the drug, according to Business Insider.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.